Latest News | Lifestyle

Drugmakers expect tests to confirm vaccines effective against new coronavirus variant

Drugmakers expect tests to confirm vaccines effective against new coronavirus variant

4 years ago
UNICEF launches Covid-19 vaccine market dashboard to ensure fair access

UNICEF launches Covid-19 vaccine market dashboard to ensure fair access

4 years ago
BioNTech confident Covid-19 vaccine effective against new UK mutation

BioNTech confident Covid-19 vaccine effective against new UK mutation

4 years ago
UK coronavirus variant may be more able to infect children: Scientists

UK coronavirus variant may be more able to infect children: Scientists

4 years ago
EU regulator gives conditional approval to BioNTech-Pfizer Covid vaccine

EU regulator gives conditional approval to BioNTech-Pfizer Covid vaccine

4 years ago
6cr doses of Covid-19 vaccine to arrive in May-June: Health minister

6cr doses of Covid-19 vaccine to arrive in May-June: Health minister

4 years ago
If masking up is answer, apathy has to be dealt with: Experts

If masking up is answer, apathy has to be dealt with: Experts

4 years ago
Bangladesh cloud kitchen business heralds improved food delivery services

Bangladesh cloud kitchen business heralds improved food delivery services

4 years ago
US approves Moderna’s Covid-19 vaccine

US approves Moderna’s Covid-19 vaccine

4 years ago
Covid vaccine delivery to poor countries to start in early 2021: WHO

Covid vaccine delivery to poor countries to start in early 2021: WHO

4 years ago
US VP Mike Pence receives Covid-19 vaccine

US VP Mike Pence receives Covid-19 vaccine

4 years ago
EU to start Covid-19 vaccination from Dec 27

EU to start Covid-19 vaccination from Dec 27

4 years ago
India expects to begin Covid-19 vaccination drive in January

India expects to begin Covid-19 vaccination drive in January

4 years ago
Moderna’s Covid-19 vaccine moves closer to US approval

Moderna’s Covid-19 vaccine moves closer to US approval

4 years ago
India's Bharat Biotech's Covaxin 'safe', triggers immune response in Phase I trial

India's Bharat Biotech's Covaxin 'safe', triggers immune response in Phase I trial

4 years ago
❮ Previous242526272829303132Next ❯
LATEST NEWS
2 months ago
A newsroom full of stories
2 months ago
The Business Post ceasing operations
2 months ago
Dhaka stocks extend positive momentum for 2 consecutive sessions
2 months ago
Interim govt boosts BKB’s capital ceiling by Tk3,500cr
2 months ago
BIMSTEC Secretary General meets Foreign Secy